Abstinence Reinforcement Therapy for Veterans Who Smoke Tobacco and Are Experiencing Homelessness
NCT07714200 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2026-07-20
Summary
Seventy to eighty percent of Veterans experiencing homelessness (VEH) smoke, which is four times the rate of the U.S. population and 2.5 times higher than among impoverished Americans. Smoking- related deaths among persons experiencing homelessness occur at double the rate seen among more stably housed people. The purpose of this study study is to evaluate the effectiveness of an intervention to help Veterans experiencing homelessness stop smoking. The intervention, called Abstinence Reinforcement Therapy + (ART+), includes telehealth-based counseling, smoking cessation aids, and mobile contingency management (mCM). mCM is an intervention in which participants are paid for smoking abstinence. 120 Veterans who smoke cigarettes and are experiencing homelessness will be randomly assigned to receive either ART+ or usual smoking cessation care. The primary outcome to be evaluated is the rate at which Veterans assigned to the ART+ condition report smoking abstinence and have their abstinence verified using salivary testing.
Conditions
- Tobacco Use Disorder
Interventions
- BEHAVIORAL
-
Cognitive Behavioral Therapy for Smoking Cessation
Five core sessions of CBT plus up to four monthly booster sessions designed to help Veterans prepare to quit smoking, make a quit attempt, and prevent relapse to smoking.
- DRUG
-
Nicotine Replacement Therapy
NRT is a group of over-the-counter medications designed to help users quit smoking. Standard of care often involves use of nicotine patch plus one rescue method (either gum or lozenge).
- DRUG
-
Bupropion is an FDA-approved prescription smoking cessation aid. Participants will be prescribed 150-300 mg.
- DRUG
-
Varenicline
Varenicline is an FDA-approved prescription smoking cessation aid. Participants will be 0.5 to 2 mg.
- BEHAVIORAL
-
Mobile Contingency Management
Smoking abstinence will be intermittently reinforced. For each carbon monoxide (CO) reading that a participant provides that suggest smoking abstinence, the participant will earn spins on a virtual prize wheel that has financial prizes.
- BEHAVIORAL
-
Clinic-Based Smoking Cessation Counseling
Participants assigned to the usual care condition may participate in group counseling for smoking cessation, which can also include use of phone-based smoking cessation resources such as a telephone quit line, a texting program, and a smoking cessation app.
Sponsors & Collaborators
-
VA Office of Research and Development
lead FED
Principal Investigators
-
Jean C Beckham, PhD · Durham VA Medical Center, Durham, NC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2027-03-01
- Primary Completion
- 2030-03-01
- Completion
- 2030-09-01
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects
NCT06254001 ·Status: RECRUITING ·Phase: PHASE4
-
Varenicline and Motivational Advice for Smokers With Substance Use Disorders
NCT00756275 ·Status: COMPLETED ·Phase: NA
-
Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)
NCT04135937 ·Status: COMPLETED ·Phase: PHASE4
-
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
NCT06966362 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Varenicline For Smokers In Recovery From Alcohol Dependence
NCT01092702 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation
NCT01772641 ·Status: TERMINATED ·Phase: PHASE4
-
Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts
NCT01023659 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment to Quit Smoking
NCT00018161 ·Status: COMPLETED ·Phase: PHASE2
-
Combinations of Pharmacologic Smoking Cessation Treatments
NCT00018187 ·Status: COMPLETED ·Phase: PHASE1
-
Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals
NCT00308763 ·Status: COMPLETED ·Phase: NA
-
Bupropion as an Adjunct to the Nicotine Patch Plus CBT
NCT00142831 ·Status: COMPLETED ·Phase: PHASE4
-
Individualizing Pharmacotherapy for African American Smokers
NCT03897439 ·Status: COMPLETED ·Phase: PHASE3
-
Varenicline Treatment for Active Alcoholic Smokers
NCT01347112 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)
NCT00000444 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolism-informed Care for Smoking Cessation
NCT03227679 ·Status: COMPLETED ·Phase: NA
-
Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment
NCT04634071 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline and Bupropion for Smoking Cessation
NCT00935818 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
NCT06118502 ·Status: RECRUITING ·Phase: NA
-
Adaptive Pharmacotherapy for Smoking Cessation
NCT02501265 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine Withdrawal Symptoms and Smoking Relapse
NCT01511614 ·Status: COMPLETED ·Phase: NA
-
The MATCH (Medication Aids for Tobacco Cessation and Health) Study
NCT02146911 ·Status: COMPLETED ·Phase: NA
-
Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers
NCT01806779 ·Status: COMPLETED ·Phase: PHASE2
-
Human Laboratory Study of Varenicline and Bupropion for Nicotine Dependence
NCT00749658 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Long-term Varenicline Treatment for Smoking Cessation
NCT00828113 ·Status: COMPLETED ·Phase: PHASE4
-
Varenicline and Alcohol in Inpatient Addictions Program (IAP)
NCT01169610 ·Status: TERMINATED ·Phase: PHASE3